Inactive Instrument
Sector Human Genome Sciences
Stocks
US4449031081
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 27/07/12 | Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources | RE |
| 16/07/12 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.00% | - | - | - | - | - | - | - | 0 | ||
| +0.19% | -3.96% | -1.44% | -11.96% | +59.30% | +54.92% | +69.15% | +10.81% | - | 65.42B | ||
| -0.14% | -3.20% | +17.59% | -2.21% | +19.73% | +7.62% | +89.74% | +238.01% | +6,141.45% | 58.91B | ||
| +0.06% | +0.15% | +8.77% | +15.16% | +24.02% | +25.94% | +87.89% | -12.01% | +265.48% | 55.24B | ||
| -0.97% | -3.91% | +7.98% | +6.06% | +31.56% | +12.98% | +113.88% | +9.65% | +1,149.06% | 45.66B | ||
| -2.83% | -7.58% | -5.77% | +0.51% | +11.15% | +15.21% | +22.34% | -6.57% | +213.66% | 41.29B | ||
| +3.61% | +2.63% | +8.48% | +10.77% | +24.72% | +21.96% | +46.39% | +17.27% | +195.61% | 36.82B | ||
| -0.24% | -9.59% | -12.47% | -25.73% | +100.16% | +126.05% | +647.44% | +435.90% | - | 34.48B | ||
| +0.03% | -0.93% | +37.57% | +62.50% | +72.52% | +76.71% | +57.74% | +27.91% | +180.66% | 32.5B | ||
| +20.58% | +22.35% | +51.60% | +10.56% | -17.00% | -29.03% | +482.03% | +374.26% | +884.06% | 31.69B | ||
| -6.39% | -12.37% | -18.16% | -17.49% | +30.28% | +27.20% | -14.67% | -61.25% | - | 22.93B | ||
| -2.26% | -4.30% | -8.78% | -28.06% | -14.52% | -19.77% | -18.12% | -71.91% | - | 20.18B | ||
| -1.99% | -3.48% | +2.31% | +4.23% | +12.88% | +7.06% | +131.37% | +179.27% | +1,661.54% | 17.73B | ||
| -5.32% | -4.16% | +11.31% | -1.41% | - | - | - | - | - | 16.79B | ||
| -3.60% | -5.74% | +5.03% | +21.03% | +50.19% | +56.22% | +211.55% | +265.11% | +288.15% | 16.06B | ||
| -1.60% | -3.78% | +9.30% | +13.08% | +64.39% | +102.88% | +73.47% | -13.68% | +346.16% | 15.71B | ||
| +0.71% | -2.61% | +8.51% | +21.23% | +37.28% | +49.23% | +62.73% | -22.28% | +103.01% | 16.06B | ||
| -3.21% | -11.72% | +2.55% | -13.93% | +184.40% | +194.75% | +309.77% | +759.92% | +686.93% | 15.12B | ||
| -2.46% | -5.06% | +13.22% | +10.36% | +4.47% | +19.87% | -29.48% | -33.49% | +149.78% | 14.26B | ||
| -4.83% | -10.71% | -14.53% | -24.95% | +1.99% | -9.01% | +340.77% | - | - | 12.86B | ||
| Average | -0.59% | -3.29% | +6.48% | +2.62% | +38.75% | +41.15% | +149.11% | +123.35% | +943.50% | 28B | |
| Weighted average by Cap. | +0.14% | -2.44% | +7.60% | +2.95% | +36.85% | +36.53% | +140.72% | +106.82% | +1,341.18% |
- Stock Market
- Stocks
- Stock
- Sector Human Genome Sciences
Select your edition
All financial news and data tailored to specific country editions
















